MCID: ADL054
MIFTS: 30

Adult Brain Stem Glioma

Categories: Bone diseases, Cancer diseases, Neuronal diseases

Aliases & Classifications for Adult Brain Stem Glioma

MalaCards integrated aliases for Adult Brain Stem Glioma:

Name: Adult Brain Stem Glioma 12 15 70
Adult Brainstem Neuroglial Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4813
NCIt 50 C9091
UMLS 70 C0278873

Summaries for Adult Brain Stem Glioma

Disease Ontology : 12 A brain stem cancer that is characterized by mass lesion of the brainstem in adulthood, associated cranial nerve nuclei and long tracts, has material basis in abnormally proliferating cells and derives from glial cells.

MalaCards based summary : Adult Brain Stem Glioma, also known as adult brainstem neuroglial tumor, is related to temporal lobe neoplasm and frontal lobe neoplasm. An important gene associated with Adult Brain Stem Glioma is MGMT (O-6-Methylguanine-DNA Methyltransferase), and among its related pathways/superpathways are Citrate cycle (TCA cycle) and Interferon Pathway. The drugs Fentanyl and Donepezil have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and spinal cord.

Related Diseases for Adult Brain Stem Glioma

Diseases in the Brain Stem Glioma family:

Adult Brain Stem Glioma

Diseases related to Adult Brain Stem Glioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 76)
# Related Disease Score Top Affiliating Genes
1 temporal lobe neoplasm 10.1 MGMT IDH1
2 frontal lobe neoplasm 10.1 MGMT IDH1
3 spinal cord oligodendroglioma 10.1 MGMT IDH1
4 gliofibroma 10.1 MGMT IDH1
5 cerebral ventricle cancer 10.1 MGMT IDH1
6 cerebrum cancer 10.1 MGMT IDH1
7 supratentorial cancer 10.1 MGMT IDH1
8 malignant giant cell tumor 10.0 H3-3B H3-3A
9 bone giant cell sarcoma 10.0 H3-3B H3-3A
10 telangiectatic osteogenic sarcoma 10.0 H3-3B H3-3A
11 colon leiomyoma 9.9 H3-3B H3-3A
12 oligoastrocytoma 9.9 MGMT IDH2
13 anaplastic oligodendroglioma 9.9 MGMT IDH2
14 bone benign neoplasm 9.9 H3-3B H3-3A
15 alpha thalassemia-x-linked intellectual disability syndrome 9.9 H3-3B H3-3A
16 enchondroma 9.9 IDH2 IDH1
17 bone giant cell tumor 9.9 H3-3B H3-3A
18 cytogenetically normal acute myeloid leukemia 9.9 IDH2 IDH1
19 intracranial chondrosarcoma 9.9 IDH2 IDH1
20 periosteal chondrosarcoma 9.9 IDH2 IDH1
21 juxtacortical chondroma 9.9 IDH2 IDH1
22 benign giant cell tumor 9.9 H3-3B H3-3A
23 gemistocytic astrocytoma 9.9 IDH2 IDH1
24 chondroblastoma 9.9 H3-3B H3-3A
25 spindle cell hemangioma 9.9 IDH2 IDH1
26 connective tissue benign neoplasm 9.9 H3-3B H3-3A
27 atypical teratoid rhabdoid tumor 9.8 IDH1 H3-3A
28 d-2-hydroxyglutaric aciduria 1 9.8 IDH2 IDH1
29 bone osteosarcoma 9.8 H3-3B H3-3A
30 2-hydroxyglutaric aciduria 9.8 IDH2 IDH1
31 l-2-hydroxyglutaric aciduria 9.8 IDH2 IDH1
32 enchondromatosis, multiple, ollier type 9.8 IDH2 IDH1
33 high grade ependymoma 9.8 MGMT IDH1 H3-3A
34 childhood acute myeloid leukemia 9.8 IDH2 IDH1
35 childhood brain stem glioma 9.8 IDH1 H3-3B H3-3A
36 childhood pilocytic astrocytoma 9.7 IDH1 H3-3B H3-3A
37 juvenile pilocytic astrocytoma 9.7 IDH1 H3-3B H3-3A
38 spinal cord glioma 9.7 IDH1 H3-3B H3-3A
39 spinal cancer 9.7 IDH1 H3-3B H3-3A
40 brain stem cancer 9.7 IDH1 H3-3B H3-3A
41 central nervous system benign neoplasm 9.7 IDH1 H3-3B H3-3A
42 pilomyxoid astrocytoma 9.7 IDH1 H3-3B H3-3A
43 oligodendroglioma 9.7 MGMT IDH2 IDH1
44 bile duct adenocarcinoma 9.7 IDH2 IDH1
45 mixed oligodendroglioma-astrocytoma 9.7 MGMT IDH2 IDH1
46 mixed glioma 9.7 MGMT IDH2 IDH1
47 low grade glioma 9.7 MGMT IDH2 IDH1
48 alpha-thalassemia 9.7 IDH1 H3-3B H3-3A
49 brain glioma 9.7 MGMT IDH2 IDH1
50 bone sarcoma 9.7 IDH2 IDH1

Graphical network of the top 20 diseases related to Adult Brain Stem Glioma:



Diseases related to Adult Brain Stem Glioma

Symptoms & Phenotypes for Adult Brain Stem Glioma

Drugs & Therapeutics for Adult Brain Stem Glioma

Drugs for Adult Brain Stem Glioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 141)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2
Donepezil Approved Phase 3 120014-06-4 3152
3
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
4
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
5 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
6 Analgesics Phase 3
7 Nootropic Agents Phase 3
8 Cola Phase 3
9 Narcotics Phase 3
10 Anesthetics Phase 3
11 Liver Extracts Phase 3
12 Anesthetics, Intravenous Phase 3
13 Anesthetics, General Phase 3
14 Analgesics, Opioid Phase 3
15 Cholinesterase Inhibitors Phase 3
16 Cholinergic Agents Phase 3
17 Central Nervous System Stimulants Phase 3
18 Neurotransmitter Agents Phase 3
19 Dexmethylphenidate Hydrochloride Phase 3
20 Dopamine Uptake Inhibitors Phase 3
21 Dopamine Agents Phase 3
22
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
23
Aldesleukin Approved Phase 2 110942-02-4, 85898-30-2
24
Levetiracetam Approved Phase 2 102767-28-2 441341
25
Pregabalin Approved, Investigational Phase 2 148553-50-8 5486971
26
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
27
Sodium citrate Approved, Investigational Phase 2 68-04-2
28
Tamoxifen Approved Phase 2 10540-29-1 2733526
29
Modafinil Approved, Investigational Phase 2 68693-11-8 4236
30
Carmustine Approved, Investigational Phase 2 154-93-8 2578
31
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
32
Sargramostim Approved, Investigational Phase 2 123774-72-1, 83869-56-1
33
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
34
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
35
Irinotecan Approved, Investigational Phase 1, Phase 2 97682-44-5, 100286-90-6 60838
36
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
37
Mercaptopurine Approved Phase 2 50-44-2 667490
38
Streptozocin Approved, Investigational Phase 2 18883-66-4 29327
39
Iodine Approved, Investigational Phase 2 7553-56-2 807
40
Acetaminophen Approved Phase 2 103-90-2 1983
41
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
42
Diphenhydramine Approved, Investigational Phase 2 147-24-0, 58-73-1 3100
43
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
44
Promethazine Approved, Investigational Phase 2 60-87-7 4927
45
Lopinavir Approved Phase 2 192725-17-0 92727
46
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
47
Citric acid Approved, Nutraceutical, Vet_approved Phase 2 77-92-9 311
48
Veliparib Investigational Phase 1, Phase 2 912444-00-9 11960529
49
Molgramostim Investigational Phase 2 99283-10-0
50
Cadexomer iodine Experimental Phase 2 94820-09-4

Interventional clinical trials:

(show top 50) (show all 55)
# Name Status NCT ID Phase Drugs
1 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
3 A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy Terminated NCT00031798 Phase 3 methylphenidate hydrochloride
4 A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma Completed NCT00498927 Phase 2 temozolomide
5 A Randomized Phase I/II Study of ABT-888 in Combination With Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma Completed NCT01026493 Phase 1, Phase 2 temozolomide 60 mg x 21 days;temozolomide 75 mg x 21 days;ABT-888 20 mg x 21 days;ABT-888 40 mg x 21 days;Temozolomide 150 mg x 5 days;ABT-888 40 mg x 5 days
6 Levetiracetam and Pregabalin for Monotherapy in Patients With Brain Tumors and Seizures. A Phase II Randomized Study. Completed NCT00629889 Phase 2 levetiracetam;pregabalin
7 A Pilot Study of Tamoxifen, Carboplatin and Topotecan in the Treatment of Recurrent or Refractory Primary Brain or Spinal Cord Tumors or Metastatic Epithelial Cancers With Central Nervous System Metastases Completed NCT00541138 Phase 2 carboplatin;tamoxifen citrate;topotecan hydrochloride
8 A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue Completed NCT01032200 Phase 2 Armodafinil
9 Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases Completed NCT00070161 Phase 2 donepezil hydrochloride
10 Phase II Treatment of Adults With Recurrent Supratentorial Low Grade Glioma With Gliadel Wafers Completed NCT00003467 Phase 2 carmustine;polifeprosan 20 with carmustine implant
11 A TRIAL OF INTENSIVE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RECONSTITUTION FOR PATIENTS BETWEEN SIX AND SIXTY YEARS OF AGE, WITH NON-PROGRESSIVE GLIOBLASTOMA MULTIFORME OR DIFFUSE INTRINSIC BRAINSTEM TUMORS, FOLLOWING INITIAL LOCAL-FIELD IRRADIATION Completed NCT00002619 Phase 2 carboplatin;thiotepa
12 Phase I Study of Intra-Tumoral, Radiolabeled, Anti-Tenascin Monoclonal Antibody 81C6 in the Treatment of Patients With Malignant Primary Brain Tumors Completed NCT00003478 Phase 1, Phase 2
13 Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies Completed NCT00002608 Phase 2 cisplatin;doxorubicin hydrochloride;tamoxifen citrate
14 Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal Completed NCT00003466 Phase 2 temozolomide
15 Phase I/II Trial of Irinotecan (CPT-11) in Patients With Recurrent Malignant Glioma Completed NCT00003616 Phase 1, Phase 2 irinotecan hydrochloride
16 A Phase II Trial of Irinotecan in Recurrent Glioma Completed NCT00003134 Phase 2 irinotecan hydrochloride
17 A Phase II Trial Of Talampanel In Patients With Recurrent High-Grade Gliomas Completed NCT00064363 Phase 2 talampanel
18 Phase II Trial Of High Dose Cyclophosphamide, Cisplatin And Carmustine With Stem Cell Reconstitution Followed By Specific Cellular Therapy In Patients With Recurrent Or Refractory Brain Tumors Completed NCT00014573 Phase 2 carmustine;cisplatin;cyclophosphamide;paclitaxel
19 Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms Completed NCT00004688 Phase 2 carmustine;mercaptopurine;streptozocin
20 PHASE II STUDY OF CARBOPLATIN (CBDCA) IN THE TREATMENT OF CHILDREN AND ADULTS WITH PROGRESSIVE LOW GRADE GLIOMAS Completed NCT00002749 Phase 2 carboplatin
21 Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms Active, not recruiting NCT00445965 Phase 2
22 Phase II Trial of Ritonavir/Lopinavir in Patients With Progressive of Recurrent High-Grade Gliomas Terminated NCT01095094 Phase 2 ritonavir;lopinavir
23 Phase II Trial of Temozolomide, Carboplatin and Neupogen in High-Grade Gliomas, Both Newly-Diagnosed and Recurrent Withdrawn NCT00006263 Phase 2 carboplatin;temozolomide
24 Photodynamic Therapy For Childhood Brain Tumors, A Phase I Study Unknown status NCT00002647 Phase 1 verteporfin
25 Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon α-2b Followed by Cisplatin, Vinblastine and Dacarbazine for Patients With Melanoma or Malignancies Potentially Responsive to SSG and/or Interferons Completed NCT00498979 Phase 1 cisplatin;sodium stibogluconate;dacarbazine;vinblastine
26 Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 Completed NCT01082926 Phase 1
27 A Pilot Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
28 Pilot Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Genetically-Modified Autologous CD8+ T Cell Clones Completed NCT00730613 Phase 1
29 A Phase I Study of Bortezomib and Temozolomide in Patients With Refractory Solid Tumors Completed NCT00544284 Phase 1 bortezomib;temozolomide
30 Phase I Dose Escalation of Gleevec in Combination With PTK787/ZK 222584 (PTK/ZK) Plus Hydroxyurea Completed NCT00387933 Phase 1 hydroxyurea;imatinib mesylate;vatalanib
31 A Phase I Trial Of CC-8490 For The Treatment Of Patients With Recurrent/Refractory High-Grade Gliomas Completed NCT00074243 Phase 1 CC-8490
32 A Phase I Trial Of A Thalidomide Analog, CC-5013, For The Treatment Of Patients With Recurrent High-Grade Gliomas Completed NCT00036894 Phase 1 lenalidomide
33 Phase I Pilot Study of Stereotaxic Radiosurgery in Patients With Intracranial Neoplasms Completed NCT00019578 Phase 1
34 Phase I GLIADEL and Continuous Infusion of Intravenous O6-Benzylguanine Trial in Patients With Recurrent Malignant Glioma Completed NCT00004892 Phase 1 O6-benzylguanine;polifeprosan 20 with carmustine implant
35 Determination of the In-Tumor-Concentration of Imatinib Mesylate in Malignant Glioma After Oral Administration Completed NCT00401024 Phase 1 imatinib mesylate
36 A Phase I Study of Concurrent Multi-modality Treatment for Patients With Relapsed Malignant Glioma Using Permanent I-125 Interstitial Seeds and Dose Escalation of Gliadel 3.85% Carmustine (BCNU) Polymer Wafers Completed NCT00003876 Phase 1 polifeprosan 20 with carmustine implant
37 A PHASE I STUDY OF THE COMBINATION OF CAI AND PACLITAXEL IN ADULT PATIENTS WITH REFRACTORY CANCERS OR LYMPHOMA Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
38 A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors Completed NCT00006368 Phase 1
39 A Pilot Study of Dose-Intensified Procarbazine, CCNU, Vincristine (PCV) for Poor Prognosis Pediatric and Adult Brain Tumors Utilizing Fibronectin-Assisted, Retroviral-Mediated Modification of CD34+ Peripheral Blood Cells With O6-Methylguanine DNA Methyltransferase Completed NCT00005796 Phase 1 lomustine;procarbazine hydrochloride;vincristine sulfate
40 Phase I Treatment of Adults With Recurrent Supratentorial High Grade Glioma With Gliadel Wafers Plus Irinotecan (CPT-11) Completed NCT00003463 Phase 1 carmustine;irinotecan hydrochloride;polifeprosan 20 with carmustine implant
41 Phase I Study of Intrathecal 131-I-3F8 Monoclonal Antibody in Patients With GD2 Positive Leptomeningeal Neoplasms Completed NCT00003022 Phase 1
42 Phase I Pharmacokinetic Trial of Thalidomide and Docetaxel: A Regimen Based on Anti-Angiogenic Therapeutic Principles Completed NCT00049296 Phase 1 docetaxel;thalidomide
43 A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas Completed NCT00020579 Phase 1 entinostat
44 A Phase I Trial of Subcutaneous And/Or Oral Calcitriol [(1,25-COH)2D3] and Carboplatin in Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
45 Mutant MGMT Gene Transfer Into Human Hematopoietic Progenitors to Protect Hematopoiesis During O6-Benzylguanine (BG, NSC 637037) and Carmustine Followed by Temozolomide Therapy of Advanced Solid Tumors Terminated NCT00003567 Phase 1 O6-benzylguanine;carmustine;temozolomide
46 Intra-Arterial Melphalan (L-Phenylalanine Mustard) Administered in Conjunction With Osmotic Blood-Brain Barrier Disruption in Patients With Brain Malignancies: A Phase I Study Terminated NCT00253721 Phase 1 Melphalan
47 A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Cancer in East Anglia, Trent and West Midlands Unknown status NCT00757614
48 A Pharmacokinetic Participation Questionnaire Study Completed NCT00890435
49 Temozolomide Induced Changes in Semen/Sperm Analysis in Men With Newly Diagnosed, Progressive or Recurrent Primary Malignant Brain Tumors Completed NCT00499798
50 Identification of Genes Involved in the Pathogenesis of Gliomas by Transcriptome Analysis Completed NCT00967200

Search NIH Clinical Center for Adult Brain Stem Glioma

Genetic Tests for Adult Brain Stem Glioma

Anatomical Context for Adult Brain Stem Glioma

MalaCards organs/tissues related to Adult Brain Stem Glioma:

40
Brain, Bone, Spinal Cord, Myeloid, Colon, Liver, Temporal Lobe

Publications for Adult Brain Stem Glioma

Variations for Adult Brain Stem Glioma

Expression for Adult Brain Stem Glioma

Search GEO for disease gene expression data for Adult Brain Stem Glioma.

Pathways for Adult Brain Stem Glioma

GO Terms for Adult Brain Stem Glioma

Cellular components related to Adult Brain Stem Glioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nuclear chromosome GO:0000228 8.96 H3-3B H3-3A
2 Barr body GO:0001740 8.62 H3-3B H3-3A

Biological processes related to Adult Brain Stem Glioma according to GeneCards Suite gene sharing:

(show all 24)
# Name GO ID Score Top Affiliating Genes
1 spermatid development GO:0007286 9.62 H3-3B H3-3A
2 positive regulation of cell growth GO:0030307 9.61 H3-3B H3-3A
3 single fertilization GO:0007338 9.61 H3-3B H3-3A
4 regulation of gene silencing by miRNA GO:0060964 9.6 H3-3B H3-3A
5 multicellular organism growth GO:0035264 9.59 H3-3B H3-3A
6 regulation of megakaryocyte differentiation GO:0045652 9.58 H3-3B H3-3A
7 negative regulation of gene expression, epigenetic GO:0045814 9.58 H3-3B H3-3A
8 oogenesis GO:0048477 9.57 H3-3B H3-3A
9 embryo implantation GO:0007566 9.56 H3-3B H3-3A
10 chromatin silencing at rDNA GO:0000183 9.55 H3-3B H3-3A
11 tricarboxylic acid cycle GO:0006099 9.54 IDH2 IDH1
12 cellular response to ionizing radiation GO:0071479 9.52 MGMT FBXO4
13 nucleus organization GO:0006997 9.51 H3-3B H3-3A
14 telomere organization GO:0032200 9.49 H3-3B H3-3A
15 DNA replication-independent nucleosome assembly GO:0006336 9.48 H3-3B H3-3A
16 muscle cell differentiation GO:0042692 9.46 H3-3B H3-3A
17 2-oxoglutarate metabolic process GO:0006103 9.43 IDH2 IDH1
18 NADP metabolic process GO:0006739 9.4 IDH2 IDH1
19 isocitrate metabolic process GO:0006102 9.37 IDH2 IDH1
20 pericentric heterochromatin assembly GO:0031508 9.32 H3-3B H3-3A
21 regulation of centromere complex assembly GO:0090230 9.26 H3-3B H3-3A
22 negative regulation of chromosome condensation GO:1902340 9.16 H3-3B H3-3A
23 telomeric heterochromatin assembly GO:0031509 8.96 H3-3B H3-3A
24 glyoxylate cycle GO:0006097 8.62 IDH2 IDH1

Molecular functions related to Adult Brain Stem Glioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor GO:0016616 9.37 IDH2 IDH1
2 nucleosomal DNA binding GO:0031492 9.32 H3-3B H3-3A
3 NAD binding GO:0051287 9.26 IDH2 IDH1
4 RNA polymerase II core promoter sequence-specific DNA binding GO:0000979 9.16 H3-3B H3-3A
5 isocitrate dehydrogenase (NADP+) activity GO:0004450 8.96 IDH2 IDH1
6 isocitrate dehydrogenase activity GO:0004448 8.62 IDH2 IDH1

Sources for Adult Brain Stem Glioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....